Jump to content

Help:Adding open license text to Wikipedia/how to

From Wikipedia, the free encyclopedia
This is an old revision of this page, as edited by Gary Lundbeck (talk | contribs) at 15:43, 22 September 2024. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Immedica Pharma AB

Immedica Pharma is a pharmaceutical company, headquartered in Stockholm, Sweden, focused on the commercialization of medicines for rare diseases and specialty care products. Immedica was founded in 2018 by its management and the investment firm Impilo. Immedica’s capabilities cover marketing and sales, compliance, pharmacovigilance, quality assurance, regulatory, medical affairs and market access, as well as a global distribution network serving patients in more than 50 countries. Immedica is fully dedicated to helping those living with diseases which have a large unmet medical need. Immedica’s therapeutic areas are primarily within genetic & metabolic diseases and hematology & oncology.